Ireland?s National Institute for Bioprocessing Research and Training (NIBRT) and Waters have announced a collaboration that will create the first database for glycan analysis by UPLC.
During the manufacture of biomolecules correct glycosylation is essential for the protein to achieve the correct structure and therapeutic efficacy. This process can be strongly influenced by many environmental factors during cell culture, such as dissolved oxygen, pH, carbon source and temperature. Given the number of possible glycan structures that can attach to a protein, it can be time-consuming to identify and quantify them all. This is why Ireland’s National Institute for Bioprocessing Research and Training (NIBRT) and Waters have announced a collaboration that will create the first database for glycan analysis by UPLC. Expected to be available in 2011, NIBRT will develop, maintain and license the database while Waters and NIBRT will co-market it worldwide.
“By combining our know-how in separations and glycan analysis with NIBRT’s expertise in glycobiology we can make fast and accurate glycosylation analysis a reality for the makers of biotherapeutics,” said Dr Jeff Mazzeo, director of biopharmaceutical business operations at Waters, in a statement. “Our goal is to simplify and introduce more certainty into the process of analyzing glycans and making quality biomolecules.”
For more information visit www.waters.com
This story originally appeared in The Column. Click here to view that issue.
Transferring Methods to Compact and Portable HPLC
February 14th 2024The current trend in laboratory equipment design is the miniaturization of laboratory instruments. Smaller-scale HPLC instruments offer benefits that cannot be matched by analytical-scale equipment, especially in the areas of portability, reduced fluid volumes, and reduced operating costs. Yet, the miniaturization of laboratory equipment has brought with it a unique set of challenges, including transferring methods to compact LC. Capillary LC expands the use of LC to applications not currently done using conventional LC in a wide array of application areas, including pharmaceutical, food and beverage, petrochemical, environmental, and oil and gas. Greg Ward, Axcend’s CEO wrote, “Customers want an HPLC system with a small footprint, low flow rates and green chemistry.” Join his podcast where he shares method transfer in these application areas.